Family · Pharmaceutical analytical standards
Nifedipine
A dihydropyridine calcium channel blocker that widens blood vessels, developed in Germany, patented in 1967 and approved in the United States in 1981; it is used for high blood pressure and angina. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It is very sensitive to light: in daylight it readily turns into a nitrosophenylpyridine derivative, so in the laboratory it is analysed in the dark or under golden light.
No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
